Bionex Pharmaceuticals

Bionex Pharmaceuticals is a private, development-stage biotech leveraging its expertise in advanced drug delivery to build a portfolio of proprietary systems and provide comprehensive CRMO services. The company's strategy is dual-pronged: advancing its own innovative delivery platforms, often with non-dilutive grant funding from entities like the NIH and NSF, while offering fee-for-service formulation and development work to external partners. Headquartered in San Diego with an operational site in North Brunswick, NJ, Bionex is positioned in the growing drug delivery sector, aiming to enhance drug efficacy, patient compliance, and lifecycle management for existing and new therapeutics.

Novel topical, transdermal/transmucosal, and implant drug delivery systems.

Bionex competes with large, established drug delivery companies (e.g., 3M, Viatris' Mylan Technologies) and numerous specialized biotechs. Its differentiation lies in its hybrid model combining grant-funded platform innovation with hands-on CRMO services for complex formulations.